Pfizer and Lilly are elbowing into the direct-to-consumer market. Will it work?

Eli Lilly and Pfizer have both recently launched direct-to-consumer platforms allowing patients to bypass an in-person doctor visit or brick-and-mortar pharmacy. Their decisions suggest large pharmaceutical companies are exploring new ways to reach patients and could indicate a growing trend.